Zodiac Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
as on 24-10-2024
- Paid Up Capital ₹ 8.96 M
as on 24-10-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.03 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.38 Cr
as on 24-10-2024
- Revenue -1.46%
(FY 2023)
- Profit -2.82%
(FY 2023)
- Ebitda -20.75%
(FY 2023)
- Net Worth 17.15%
(FY 2023)
- Total Assets 18.27%
(FY 2023)
About Zodiac Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 8.96 M.
The company currently has active open charges totaling ₹11.03 Cr. The company has closed loans amounting to ₹4.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gannabathula Babu and Gannabathula Rajitha serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC044453
- Company No.
044453
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zodiac Life Sciences Private Limited offer?
Zodiac Life Sciences Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Consumables, Analyzers & Analytical Instruments, Chromatography Column, HPLC Column.
Who are the key members and board of directors at Zodiac Life Sciences?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gannabathula Rajitha | Managing Director | 19-Oct-2004 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gannabathula Babu | Director | 19-Oct-2004 | Current |
Financial Performance of Zodiac Life Sciences.
Zodiac Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.46% decrease. The company also saw a slight decrease in profitability, with a 2.82% decrease in profit. The company's net worth Soared by an impressive increase of 17.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Zodiac Life Sciences?
In 2023, Zodiac Life Sciences had a promoter holding of 59.67% and a public holding of 40.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Scintillate Pharma Private LimitedActive 3 years 1 month
Gannabathula Babu and Gannabathula Rajitha are mutual person
- Roshini Hospital Private LimitedActive 6 years 17 days
Gannabathula Babu and Gannabathula Rajitha are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 15 Jul 2024 | ₹8.45 M | Open |
Sidbi Creation Date: 20 Jul 2022 | ₹1.43 Cr | Open |
Axis Bank Limited Creation Date: 17 Feb 2022 | ₹0.80 M | Open |
How Many Employees Work at Zodiac Life Sciences?
Zodiac Life Sciences has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zodiac Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zodiac Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.